BMY
Bristol-Myers Squibb Company · Healthcare · Drug Manufacturers - General
Momentum-inputs (vergelijkbare managers):
breedte van houders +5.3% ·
aandelenstroom +6.8% ·
netto nieuwe posities +5.0%
— formule
Brede accumulatie — stijgende aandelen bij meer houders
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q3 2024
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q2 2026 | 174 | +1 | 1.33B | $76.47B | +6 | −4 |
| Q1 2026 | 175 | +1 | 1.27B | $76.90B | +4 | −4 |
| Q4 2025 | 173 | +1 | 1.36B | $73.29B | +2 | — |
| Q3 2025 | 26 | 0 | 840.35M | $37.89B | — | −1 |
| Q2 2025 | 24 | +1 | 649.62M | $30.06B | +2 | −1 |
| Q1 2025 | 20 | 0 | 256.22M | $15.62B | +1 | −1 |
| Q4 2024 | 20 | -1 | 253.42M | $14.33B | — | −1 |
| Q3 2024 | 20 | +1 | 169.93M | $8.78B | +1 | — |
| Q2 2024 | 19 | — | 159.17M | $6.60B | — | — |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Geode Capital Management ✦ (passief) | 43.20M | +2.5% | $2.23B | 0.2% | ▲ Add | 2 | SEC ↗ |
| 2 | Geode Capital Management ✦ (passief) | 43.20M | +2.5% | $2.23B | 0.2% | ▲ Add | 2 | SEC ↗ |
| 3 | Norges Bank ✦ (passief) | 34.38M | +5.5% | $1.78B | 0.2% | ▲ Add | 2 | SEC ↗ |
| 4 | PRIMECAP Management ✦ | 23.37M | -0.6% | $1.21B | 0.9% | ▼ Trim | 2 | SEC ↗ |
| 5 | T. Rowe Price ✦ | 20.24M | +32.3% | $1.05B | 0.1% | ▲ Add | 2 | SEC ↗ |
| 6 | T. Rowe Price ✦ | 20.24M | +32.3% | $1.05B | 0.1% | ▲ Add | 2 | SEC ↗ |
| 7 | Dodge & Cox ✦ | 15.63M | -0.9% | $808.58M | 0.5% | ▼ Trim | 2 | SEC ↗ |
| 8 | Millennium Management ✦ | 5.19M | +247.9% | $268.29M | 0.2% | ▲ Add | 2 | SEC ↗ |
| 9 | Citadel Advisors ✦ | 5.12M | -53.5% | $263.16M | 0.3% | ▼ Trim | 2 | SEC ↗ |
| 10 | Citadel Advisors ✦ | 5.12M | -53.5% | $263.16M | 0.3% | ▼ Trim | 2 | SEC ↗ |
| 11 | Citadel Advisors ✦ | 5.12M | -53.5% | $263.16M | 0.3% | ▼ Trim | 2 | SEC ↗ |
| 12 | Two Sigma Investments ✦ | 4.72M | -23.5% | $244.28M | 0.6% | ▼ Trim | 2 | SEC ↗ |
| 13 | Adage Capital Partners ✦ | 4.49M | +415.6% | $232.53M | 0.4% | ▲ Add | 2 | SEC ↗ |
| 14 | AQR Capital Management ✦ | 3.90M | +45.7% | $200.47M | 0.3% | ▲ Add | 2 | SEC ↗ |
| 15 | AQR Capital Management ✦ | 3.90M | +45.7% | $200.47M | 0.3% | ▲ Add | 2 | SEC ↗ |
| 16 | AQR Capital Management ✦ | 3.90M | +45.7% | $200.47M | 0.3% | ▲ Add | 2 | SEC ↗ |
| 17 | AQR Capital Management ✦ | 3.90M | +45.7% | $200.47M | 0.3% | ▲ Add | 2 | SEC ↗ |
| 18 | AQR Capital Management ✦ | 3.90M | +45.7% | $200.47M | 0.3% | ▲ Add | 2 | SEC ↗ |
| 19 | Point72 Asset Management ✦ | 2.88M | +351.5% | $149.03M | 0.5% | ▲ Add | 2 | SEC ↗ |
| 20 | Arrowstreet Capital ✦ | 2.03M | -30.4% | $105.09M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 21 | D. E. Shaw & Co. ✦ | 1.56M | -36.5% | $80.65M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 22 | D. E. Shaw & Co. ✦ | 1.56M | -36.5% | $80.65M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 23 | Renaissance Technologies ✦ | 908.54K | Nieuw | $47.01M | 0.1% | New | 1 | SEC ↗ |
| 24 | Marshall Wace ✦ | 868.11K | +239.5% | $44.92M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 25 | Bridgewater Associates ✦ | 610.36K | +10.0% | $31.58M | 0.2% | ▲ Add | 2 | SEC ↗ |
| 26 | Gotham Asset Management ✦ | 337.01K | +17.5% | $17.44M | 0.2% | ▲ Add | 2 | SEC ↗ |
| 27 | Fisher Asset Management ✦ | 226.48K | -0.7% | $11.72M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 28 | Wellington Management ✦ | 150.19K | -9.9% | $7.77M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 29 | Wellington Management ✦ | 150.19K | -9.9% | $7.77M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 30 | Wellington Management ✦ | 150.19K | -9.9% | $7.77M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 31 | Wellington Management ✦ | 150.19K | -9.9% | $7.77M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 32 | GAMCO Investors ✦ | 110.89K | -0.5% | $5.74M | 0.1% | ▼ Trim | 2 | SEC ↗ |
"Hun gewicht" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die beheerder — de overtuigingsmaatstaf. ✦ = gecureerde beheerder.
Nieuwe kopers
| Renaissance Technologies | $47.01M | 0.1% |
Verlaten
| Geen bijgehouden uitstappen dit kwartaal. |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 1 houders, 6.60K aandelen, $400 gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect verder het vaakst bezitten — aantallen gedeeld eigendom, geen fundamentele relaties.